Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 10, 1998
[Telomeres, telomerase and development of cancer]T I AndersenTidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 10, 1998
[Diagnostic molecular biology in prostatic cancer]T I AndersenActa Oncologica (Stockholm, Sweden)|January 1, 1996
Genetic heterogeneity in breast cancer susceptibilityT I AndersenDiagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|September 1, 1995
Alterations of the TP53 gene as a potential prognostic marker in breast carcinomas. Advantages of using constant denaturant gel electrophoresis in mutation detectionT I Andersen, A L BørresenTidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 6, 1998
[Diagnostic molecular biology in breast cancer]T I Andersen, A L Børresen-DaleBreast Cancer Research and Treatment|May 23, 1998
Mutation screening of BRCA1 using PTT and LOH analysis at 17q21 in breast carcinomas from familial and non-familial casesT Sørlie, T I Andersen, I Bukholm, et al.Genes, Chromosomes & Cancer|November 1, 1990
Breast cancer and other cancers in Norwegian families with ataxia-telangiectasiaA L Børresen, T I Andersen, S Tretli, et al.Human Genetics|March 1, 1993
Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomasA Lindblom, L Skoog, T I Andersen, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Detection of c-erbB-2 related protein in sera from breast cancer patients. Relationship to ERBB2 gene amplification and c-erbB-2 protein overexpression in tumourT I Andersen, E Paus, J M Nesland, et al.Human Genetics|December 1, 1994
Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibilityT I Andersen, K R Heimdal, M Skrede, et al.Pageof 5